C9029 HCPCS code: Injection, guselkumab, 1 mg
C9029 is the HCPCS Level II code for injection, guselkumab, 1 mg. CMS terminated C9029 on 2018-12-31; do not bill it for later dates of service. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | O1E — Other drugs |
| Added | 2018-01-01 |
| Last action effective | 2019-01-01 |
| Terminated | 2018-12-31 |
What changed for C9029
- 2018-01-01: C9029 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9029?
C9029 is the HCPCS Level II code for injection, guselkumab, 1 mg. Short descriptor: "Injection, guselkumab".
Does Medicare cover C9029?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related C90 codes
- C9014 — Injection, cerliponase alfa, 1 mg
- C9015 — Injection, c-1 esterase inhibitor (human), haegarda, 10 units
- C9016 — Injection, triptorelin extended release, 3.75 mg
- C9021 — Injection, obinutuzumab, 10 mg
- C9022 — Injection, elosulfase alfa, 1mg
- C9023 — Injection, testosterone undecanoate, 1 mg
- C9024 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- C9025 — Injection, ramucirumab, 5 mg
- C9026 — Injection, vedolizumab, 1 mg
- C9027 — Injection, pembrolizumab, 1 mg
- C9028 — Injection, inotuzumab ozogamicin, 0.1 mg
- C9030 — Injection, copanlisib, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9029
- Watch C9029 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9029
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.